Newsroom

West Point Pharma Launches AI-Powered Assistant to Enhance Customer Support Experience Introduces Intelligent AI Service for Faster Pharmaceutical Excipient Consultation As part of our commitment to improving global customer experience and digital innovation, West Point Pharma has officially launched its AI-powered intelligent assistant system on our website. The new AI system is designed to provide customers with a faster and more convenient way to access information related to pharmaceutical excipients, product applications, and industry knowledge.   Smarter Communication, Better Support   In the pharmaceutical industry, customers often need professional information regarding excipient selection, product specifications, application scenarios, and technical requirements. With the integration of AI technology, customers can now receive instant assistance for common industry-related questions, including: Pharmaceutical excipient applications MCC, Mannitol, DCPA, SMCC and other product information Direct compression formulation considerations Technical document guidance General pharmaceutical industry inquiries The AI assistant helps reduce communication time and provides customers with a more efficient information access experience.   Supporting Global Customers with Digital Innovation   As an international pharmaceutical excipients supplier, West Point Pharma continuously explores new ways to improve cooperation efficiency with customers worldwide. The launch of this AI system represents another step toward digital transformation, enabling us to provide more responsive and accessible support for pharmaceutical companies, distributors, and partners across different markets.   Continuous Improvement for a Better Customer Experience   Technology continues to reshape the pharmaceutical industry. By combining professional expertise with advanced digital tools, West Point Pharma aims to create a more efficient and customer-focused service platform. We will continue investing in innovation, improving our digital services, and supporting customers with reliable pharmaceutical excipient solutions.

Showcasing High-Quality Pharmaceutical Excipients and Connecting with Global Industry Partners   Westpoint Pharma has successfully concluded its participation in CPHI China 2026, one of Asia’s most influential pharmaceutical exhibitions, held in Shanghai. The exhibition provided an excellent platform for pharmaceutical companies, industry professionals, and global partners to exchange insights on the latest developments in pharmaceutical ingredients, excipients, and formulation technologies. During the exhibition, Westpoint Pharma presented its comprehensive portfolio of pharmaceutical excipient solutions, including: Microcrystalline Cellulose (MCC) Mannitol Anhydrous Dicalcium Phosphate (DCPA) Silicified Microcrystalline Cellulose (SMCC) Hydroxypropyl Methylcellulose (HPMC) These products are widely applied in solid dosage formulations, including tablets and capsules, supporting pharmaceutical manufacturers with improved compressibility, flowability, stability, and formulation performance.   Successful Communication with Global Pharmaceutical Professionals   During CPHI China 2026, Westpoint Pharma had the opportunity to meet and communicate with pharmaceutical professionals from around the world. Our high-quality pharmaceutical excipient solutions, including MCC, Mannitol, DCPA, SMCC, and HPMC, received positive feedback and recognition from international customers.   Through face-to-face discussions, customers gained a deeper understanding of our product quality, manufacturing capabilities, and technical support services. The trust and recognition from global partners encourage us to continuously improve our excipient solutions and provide more reliable support for pharmaceutical manufacturers worldwide.   Delivering Reliable Pharmaceutical Excipient Solutions Worldwide As a professional pharmaceutical excipients manufacturer, Westpoint Pharma is committed to providing high-quality excipient products and technical support for global pharmaceutical companies.   Through continuous improvement in manufacturing technology, quality management, and application expertise, Westpoint Pharma aims to support customers in developing efficient and reliable pharmaceutical formulations. The successful conclusion of CPHI China 2026 marks another important milestone in Westpoint Pharma’s global expansion journey. We look forward to building long-term partnerships and creating more opportunities with pharmaceutical professionals around the world.   About Westpoint Pharma Westpoint Pharma specializes in the development and manufacturing of pharmaceutical excipients, offering high-quality solutions including Microcrystalline Cellulose (MCC), Mannitol, DCPA, SMCC, and HPMC. With advanced manufacturing capabilities, strict quality control systems, and professional technical support, Westpoint Pharma provides reliable excipient solutions for pharmaceutical manufacturers worldwide.  

Westpoint Pharma Expands Global Collaboration Through Customer Visit in India   As one of the world's leading pharmaceutical markets, India plays an important role in global drug development and manufacturing. To strengthen cooperation with international customers and better understand market demands, the Westpoint Pharma team recently visited pharmaceutical partners in India for in-depth discussions and technical exchanges.   Visiting Indian Pharmaceutical Partners   During the visit to India, the Westpoint Pharma team held in-depth discussions with leading pharmaceutical companies, including Dr. Reddy’s Laboratories and Hetero. Through comprehensive communication and technical exchanges, both sides explored future cooperation opportunities and reached strategic cooperation intentions.         The Indian pharmaceutical partners highly recognized Westpoint Pharma’s product performance, advanced manufacturing capabilities, quality management systems, and comprehensive certification standards. The discussions also highlighted the growing demand for high-performance pharmaceutical excipients in the Indian market, especially as local pharmaceutical companies continue to pursue higher quality standards and advanced formulation technologies.   Through this strategic engagement, Westpoint Pharma aims to further strengthen cooperation with Indian pharmaceutical companies, provide reliable excipient solutions, and contribute to the continuous development and advancement of the high-end pharmaceutical industry in India.        

Introduction At CPhI Shanghai 2026, Westpoint Pharma will showcase its comprehensive pharmaceutical excipient portfolio, including Microcrystalline Cellulose (MCC), Silicified Microcrystalline Cellulose (SMCC), Mannitol, and other high-quality excipient solutions. We look forward to meeting global pharmaceutical professionals and discussing how our excipient technologies can support formulation development and manufacturing excellence.     About CPhI Shanghai CPhI Shanghai is a globally recognized platform for pharmaceutical industry exchange, bringing together leading companies across APIs, pharmaceutical excipients, finished dosage forms, equipment, and related services. The exhibition provides valuable opportunities for industry professionals to explore innovative technologies, strengthen supply chain partnerships, and promote collaboration throughout the pharmaceutical value chain.   Product Highlights at CPhI Shanghai Westpoint Pharma is a professional pharmaceutical excipients manufacturer, providing high-quality excipient solutions for global pharmaceutical companies. Our core product portfolio includes Microcrystalline Cellulose (MCC), Mannitol, Dibasic Calcium Phosphate Anhydrous (DCPA), Hydroxypropyl Methylcellulose (HPMC), and Silicified Microcrystalline Cellulose (SMCC). With advanced manufacturing technology, strict quality control, and technical support capabilities, we are committed to delivering reliable pharmaceutical excipients that support direct compression, oral solid dosage formulations, and various drug development needs.     Exhibition Information Item Details Exhibition CPhI Shanghai 2026 Company Westpoint Pharma Booth No. Hall E3 E3E46 Date 06.16-06.18 Venue Shanghai, China